189 related articles for article (PubMed ID: 12478679)
1. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
Rowe LR; Marshall CJ; Bentz JS
Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
[TBL] [Abstract][Full Text] [Related]
2. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
3. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
4. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
Wertlake P
J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
6. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions.
Islam S; West AM; Saboorian MH; Ashfaq R
Cancer; 2004 Apr; 102(2):67-73. PubMed ID: 15098249
[TBL] [Abstract][Full Text] [Related]
7. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
[TBL] [Abstract][Full Text] [Related]
8. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
9. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
[TBL] [Abstract][Full Text] [Related]
11. Rescreening in gynecologic cytology. Rescreening of 3762 previous cases for current high-grade squamous intraepithelial lesions and carcinoma--a College of American Pathologists Q-Probes study of 312 institutions.
Jones BA
Arch Pathol Lab Med; 1995 Dec; 119(12):1097-103. PubMed ID: 7503656
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
Colgan TJ; Patten SF; Lee JS
Acta Cytol; 1995; 39(6):1191-8. PubMed ID: 7483997
[TBL] [Abstract][Full Text] [Related]
13. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
Marshall CJ; Rowe L; Bentz JS
Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
[TBL] [Abstract][Full Text] [Related]
14. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
Jensen ML; Dybdahl H; Svanholm H
Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
[TBL] [Abstract][Full Text] [Related]
15. [The PAPNET system in cytological rescreening of cervical smears].
Cenci M; Nagar C; Giovagnoli MR; Vecchione A
Minerva Ginecol; 1997 Apr; 49(4):139-45. PubMed ID: 9206764
[TBL] [Abstract][Full Text] [Related]
16. The PAPNET system for quality control of cervical smears: validation and limits.
Cenci M; Nagar C; Giovagnoli MR; Vecchione A
Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
[TBL] [Abstract][Full Text] [Related]
17. Automated screening for quality control using PAPNET: a study of 638 negative Pap smears.
Keyhani-Rofagha S; Palma T; O'Toole RV
Diagn Cytopathol; 1996 Jun; 14(4):316-20. PubMed ID: 8725131
[TBL] [Abstract][Full Text] [Related]
18. [Automation of cytological analysis of cervical smears].
Cenci M; Giovagnoli MR; Olla SV; Drusco A; Vecchione A
Minerva Ginecol; 1999; 51(7-8):291-8. PubMed ID: 10536424
[TBL] [Abstract][Full Text] [Related]
19. [Applicative aspects of liquid-based cytology in cervical cancer screening].
Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
[TBL] [Abstract][Full Text] [Related]
20. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study.
Schledermann D; Ejersbo D; Hoelund B
Cytopathology; 2004 Jun; 15(3):148-53. PubMed ID: 15165271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]